Committee backs bill to expand Medicaid access to continuous glucose monitors
Senate Bill 521 (as amended) would expand Medicaid coverage for continuous glucose monitors (CGMs) for patients with insulin‑treated diabetes and certain rare glycogen storage disease cases; clinicians testified CGMs improve outcomes and reduce hospitalization; sponsor estimated a potential cost of about $15 million if fully utilized.
The full story
Senate Bill 521, as amended, would require Medicaid to cover continuous glucose monitors (CGMs) for beneficiaries with insulin‑treated diabetes who meet frequency or hypoglycemia criteria and for individuals with certain glycogen storage diseases. Sponsor Senator Davis and clinician witnesses said the change aligns Arkansas with most other states and would improve care while reducing long‑term costs.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in